Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Etifoxine aids peripheral nerve recovery

Jan. 9, 2009

GSK scientists describe new AMPA receptor agonists in recent patent

Jan. 8, 2009

Chalcone derivative blocks Abeta impairment of PKA/CREB signaling

Jan. 8, 2009

GlaxoSmithKline reports on discovery of EP1 receptor antagonist for inflammatory pain

Jan. 8, 2009

FDA approves once-daily Ryzolt for moderate to moderately severe pain

Jan. 7, 2009

King provides update on Embeda NDA review

Jan. 7, 2009

Acura and King Pharmaceuticals submit NDA to FDA for Acurox anti-abuse opioid analgesic

Jan. 7, 2009

IGF-1 does not affect outcome measures in phase III amyotrophic lateral sclerosis trial

Jan. 7, 2009

New mgluR2 ligands/5-HT2A antagonists described in Abbott patent

Jan. 5, 2009

Urigen amends licence agreement with UCSD for URG-101

Jan. 5, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...